Codex DNA Inc (DNAY) has fallen Tuesday morning, with the stock decreasing -2.13% in pre-market trading to 1.84. DNAY's short-term technical score of 14 indicates that the stock has traded less bullishly over the last month than 86% of stocks on the market. In the Medical Devices industry, which ranks 119 out of 146 industries, Codex DNA Inc ranks higher than 19% of stocks. Codex DNA Inc has fallen 11.74% over the past month, closing at $2.29 on June 28. During this period of time, the stock fell as low as $1.70 and as high as $2.41. DNAY has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.
DNAY has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on DNAY!